A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment—USMIRC Group.
Saved in:
| Title: | A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment—USMIRC Group. |
|---|---|
| Authors: | Hameed, Maha1 (AUTHOR), Habib, Alma2 (AUTHOR), Khan, Abdullah Mohammad3 (AUTHOR), Laharwal, Mehak Masood4 (AUTHOR), Mewawalla, Prerna4,5 (AUTHOR), McKenna, Marshall5,6 (AUTHOR), Tiger, Yun Kyuong Ryu5,7 (AUTHOR), Shah, Mansi5,8 (AUTHOR), Shaikh, Hira1,6 (AUTHOR), Strouse, Christopher2,6 (AUTHOR), Green, Kimberly3,7 (AUTHOR), Snyder, Jordan2,4 (AUTHOR), Mahmoudjafari, Zahra2,5 (AUTHOR), Mushtaq, Muhammad Umair2,6 (AUTHOR), Ahmed, Nausheen2,7 (AUTHOR), Abdallah, Al-Ola2,8 (AUTHOR), Atrash, Shebli8 (AUTHOR), Paul, Barry8 (AUTHOR), Friend, Reed8 (AUTHOR) |
| Source: | Cancers. Mar2026, Vol. 18 Issue 5, p740. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
